Project Grant R21CA313908
Award Date 9/1/26
Completion Date 8/31/28
Dollars Obligated $447K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
- The National Cancer Institute awarded the University of Illinois $665,257 on September 3, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop molecular diagnostic methods for cervical cancer screening. The recipient will develop and validate a loop-mediated isothermal amplification (LAMP)-based assay for detecting high-risk human papillomavirus (HPV) infection in cervical samples, designed for point-of-care deployment in low-resource settings where access...
- Federal Grant Award Summary The National Cancer Institute awarded a $371,161 Project Grant to the University of Colorado-Denver under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) on September 1, 2025, for a two-year performance period concluding August 31, 2027. The award funds the development of artificial intelligence (AI) algorithms designed to improve cervical cancer screening in low-resource settings. Specifically, the project will create advanced AI risk stratification...
- The National Cancer Institute awarded the University of Washington $203,939 on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to implement a team-based care model designed to increase cervical cancer screening uptake in low-resource primary care settings. The project, titled "Implementing a Team-Based Care Model to Increase Cervical Cancer Screening Uptake in Low-Resource Primary Care Settings," addresses persistently low screening rates in rural and...
- The National Cancer Institute, part of the Department of Health and Human Services National Institutes of Health, awarded the University of California, Los Angeles $518,451 on June 2, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to leverage multimodal signatures to personalize rectal cancer radiotherapy choice. The project runs through May 31, 2031, with performance based in Los Angeles, California. The research addresses rectal cancer, which comprises...
- Federal Project Grant Award Summary The National Cancer Institute awarded a $498,565 Project Grant to The University of Texas MD Anderson Cancer Center on September 8, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to develop a Globally Accessible and Pragmatic Predictive Signature (GAPPS) for locally advanced cervical cancer. The project, which extends through July 31, 2029, addresses a critical clinical need to risk-stratify cervical cancer patients undergoing...
- The National Cancer Institute awarded The Regents of the University of California, San Francisco $132,618 on December 1, 2025, under the Cancer Research Manpower program (CFDA 93.398) to support mentored training for a PhD student in epidemiology at UCSF to become a researcher in cancer health disparities. The award funds a Ruth L. Kirschstein National Research Service Award (F31) that provides the trainee with expertise in translational research, geospatial data analysis, and causal inference...
- Federal Project Grant Award Summary Award Details: Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) received a $3.28 million Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393). The award was obligated on August 15, 2025, with a project completion date of July 31, 2029. Products and Services: The funded project will develop and deliver English and Spanish-language smartphone-based Embodied...
- Federal Project Grant Award Summary New York University received a $442,750 Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), with performance extending from September 23, 2025 through August 31, 2027. This research initiative delivers a systematic, theory-driven analysis of implementation strategies for cervical cancer control policies in African low- and middle-income countries (LMICs). The project employs a rigorous...
- The National Institutes of Health National Cancer Institute awarded Wayne State University $155,000 on May 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to investigate multi-level predictors of diagnostic follow-up attendance after an abnormal cervical cancer screen. The project will identify individual-level and clinic-level barriers and facilitators to diagnostic follow-up completion among women who receive abnormal cervical cancer screening results. Current...
- The National Cancer Institute awarded the University of Hawaii $555,703 on August 13, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to identify biological mechanisms and risk factors contributing to the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer among Asian American and Native Hawaiian/Pacific Islander (AANHPI) populations. The research addresses a clinical gap: fewer than 50 percent of DCIS patients progress to invasive cancer, yet no...